
Join to view full profile
200 1st Street SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Gill is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paula Gill is an Assistant Professor in Oncology specializing in Gynecologic Oncology. She is currently a Consultant in Medical Oncology at the Mayo Clinic in Rochester, MN. She completed her Residency in Internal Medicine at The MetroHealth System/Case Western Reserve University in Cleveland, OH and her Fellowship in Hematology and Medical Oncology at the Mayo Clinic. She previously served as the Chairperson of Oncology at Mayo Clinic Health System in Southwest Wisconsin and then in Southeast Minnesota. She was the Vice Chair and Practice Chair of the Mayo Clinic Health System Division of Community Oncology. She developed an interest in Gynecologic malignancies including endometrial, cervical and ovarian cancer and transitioned her practice from the community to Mayo Clinic Rochester to focus on this specialty. She currently serves as the Gyn Oncology Tumor Group Chair in Rochester. Dr. Gill also has an interest in cellular therapy, is FACT certified, and participates in the care and oversight of patients receiving these innovative therapies. Her achievements have been recognized with multiple CMS Meaningful Use Stage Certifications.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2002 - 2005
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1998 - 2002
Case Western Reserve University School of MedicineClass of 1998
Certifications & Licensure
IA State Medical License 2008 - 2028
MN State Medical License 2021 - 2027
WI State Medical License 2005 - 2027
OH State Medical License 2000 - 2003
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014-2017
Clinical Trials
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Publications & Presentations
PubMed
- Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2.Mohamed A Aboelatta, Jabra Zarka, Nika Tchatchua, Noureldin A Aboelatta, Jeffrey E Johnson
Current Oncology. 2026-06-24 - 67 citationsEvaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)Debra L. Barton, Jeff A. Sloan, Lynne T. Shuster, Paula Gill, Patricia C. Griffin
Supportive Care in Cancer. 2018-02-01 - 20 citationsHigh-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.Paula Gill, Mark R. Litzow, Jan C. Buckner, Carola A.S. Arndt, Timothy J. Moynihan
Cancer. 2008-04-15
Press Mentions
Masking Questions: How Pandemic Health Measures Became PoliticizedJuly 3rd, 2020
Navigating Breast Cancer with Support and StrengthMarch 18th, 2019
Mayo-Franciscan Plans $4.6 Million Cancer Center Project as Patients DoubleNovember 14th, 2017
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- European Society of Medical OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









